Healthex News

Seroba Takes Part in World HealthEx Forum

The World HealthEx Forum & Inv€$tival Showcase takes place in London on the 13th & 14th November 2017.  The event is produced by Biotech and Money in partnership with Jefferies.

Steve Atkinson, CEO of Atlantic Therapeutics, will present the INNOVO® story at the conference on Monday 13th and Daniel O’Mahony of Seroba Life Sciences will also take part in the discussions during the Forum.

Daniel O’Mahony is also part of the Keynote Panel on Funding New Frontiers on Tuesday 14th.  The topic for the keynote panel is ‘The evolving roles of new and existing players in funding innovation and getting drugs and technologies to market quicker.’



The World HealthEx Forum is a powerful 2 day forum for the most innovative board level industry executives involved in shaping the future of health. World HealthEx Forum connects multidisciplinary global healthcare leaders that will address key challenges head on, and provide genuine outcomes for the executives in attendance and the sector as a whole.

World HealthEx Forum has three core benefits:

Firstly, it is a world healthcare leaders forum that is strong on engagement and peer-to-peer sharing of experience and knowledge. With such a wealth of talent and experience gathered round the table, genuine learning and idea generation is paramount. Everyone participates. No-one is simply a delegate.

Secondly, the forum is a vehicle for not just new ideas, but for genuine positive and actionable outcomes – both for the CEOs present, but also for the sector as a whole.

Thirdly, it connects leaders across healthcare subsectors with industry leading investors, encompassing a therapeutics focused investment showcase within the biggest week of European healthcare investment.

To learn more, please click here.

Recent Articles

Endotronix News

Endotronix Enrolls 1st Patient in SIRONA II CE Mark Trial

LISLE, IL – JULY 15, 2019 – Endotronix, Inc., a digital health and medical technology company dedicated to advancing the […]

Read More
Home V2

Seroba Invests in Storm Therapeutics

20 May 2019.  STORM Therapeutics (“STORM”), the drug discovery company tackling disease through modulating RNA modifying enzymes, has announced that […]

Read More
Quanta SC+

Quanta SC+ confirmed as safe and easy to use

Alcester, Warwickshire, UK, 15 April 2019.  Seroba’s portfolio company, Quanta Dialysis Technologies Ltd (“Quanta” or the “Company”), a pioneering medical […]

Read More

Fusion Raises $105m in Series B Financing

April 2nd 2019. Hamilton, Canada and Dublin, Ireland.  Seroba’s portfolio company, Fusion Pharmaceuticals, a clinical-stage biopharmaceutical company developing targeted alpha-particle […]

Read More
T: 353 (0)1 633 4028

18 Herbert Street
Dublin 2
D02 FK19

Scroll to Top